H.R. 1864 (119th)Bill Overview

Risky Research Review Act

Health|Accounting and auditingAdvisory bodies
Cosponsors
Support
Republican
Introduced
Mar 5, 2025
Discussions
Bill Text
Current stageCommittee

Referred to the Committee on Science, Space, and Technology, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in…

Introduced
Committee
Floor
President
Law
Congressional Activities
01 · The brief

Creates an independent Life Sciences Research Security Board to review and make binding determinations on federal funding for defined high-risk life sciences research (dual-use, gain-of-function, high-consequence pathogens).

Establishes Board membership, conflict-of-interest rules, security clearances, review procedures, applicant attestations, agency referral obligations, enforcement mechanisms, reporting requirements, GAO audits, staff limits, and authorizes $30 million annually for 2026–2035.

Passage35/100

Technically specific and security‑oriented, so attractable, but creates new binding federal body and regulatory burden that invites sustained scrutiny and potential opposition.

CredibilityPartial

How solid the drafting looks.

Contention68/100

Liberal emphasizes public-health protections and oversight benefits

02 · What it does

Who stands to gain, and who may push back.

Who this appears to help vs burden50% / 50%
Federal agenciesFederal agencies
Likely helped
  • Federal agenciesCentralized, binding federal review authority for high-risk life sciences research improves consistent risk oversight.
  • Targeted stakeholdersStandardized biosafety, biosecurity, and personnel requirements across agencies may reduce risky research practices.
  • Federal agenciesMandatory attestations and disclosures improve traceability and accountability of federally funded life sciences projec…
Likely burdened
  • Targeted stakeholdersAdds preaward review steps that may delay grant awards and research starts.
  • Federal agenciesBinding Board authority may override agency expertise, centralizing federal control over scientific funding.
  • Targeted stakeholdersAdditional compliance, attestation, reporting, and subcontractor disclosures increase administrative burden and costs f…
03 · Why people split

Why the argument around this bill splits.

Liberal emphasizes public-health protections and oversight benefits
Progressive80%

Likely broadly supportive of independent oversight to prevent misuse of dangerous biological research while protecting public health.

Would welcome mandatory review, disclosure, and stronger biosafety/security requirements but watch for excessive secrecy or barriers to legitimate public-health research.

Leans supportive
Centrist65%

Views the bill as a pragmatic step to close oversight gaps around risky research but cautious about duplication, timelines, and operational details.

Would favor amendments ensuring clear coordination, predictable review timelines, and minimized disruption to legitimate research.

Split reaction
Conservative20%

Skeptical of creating a new independent agency with binding authority over agency grants; views this as federal overreach that could stifle innovation, impose costs, and politicize science.

May accept targeted measures for national security but oppose broad supervisory powers.

Likely resistant
04 · Can it pass?

The path through Congress.

Introduced

Reached or meaningfully advanced

Committee

Reached or meaningfully advanced

Floor

Still ahead

President

Still ahead

Law

Still ahead

Passage likelihood35/100

Technically specific and security‑oriented, so attractable, but creates new binding federal body and regulatory burden that invites sustained scrutiny and potential opposition.

Scope and complexity
52%
Scopemoderate
86%
Complexityhigh
Why this could stall
  • Level and coordination of scientific community lobbying against provisions
  • Agency willingness and logistics to provide classified access and support
05 · Recent votes

Recent votes on the bill.

No vote history yet

The bill has not accumulated any surfaced votes yet.

06 · Go deeper

Go deeper than the headline read.

Included on this page

Liberal emphasizes public-health protections and oversight benefits

Technically specific and security‑oriented, so attractable, but creates new binding federal body and regulatory burden that invites sustain…

Unlocked analysis

Pro readers get the full perspective split, passage barriers, legislative design review, stakeholder impact map, and lens-based policy tradeoff analysis for Risky Research Review Act.

Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.

Perspective breakdownsPassage barriersLegislative design reviewStakeholder impact map
Open full analysis